FIDURA Private Equity Fonds

Klaus Ragotzky is listed as the firm’s Geschäftsführer (managing director) on its website, with no additional investment committee or named partners disclosed. Public materials do not clarify whether he retains sole investment authority or works alongside a broader team.

FIDURA operates as an emissionshaus — a specialized German entity that issues closed-end funds — pooling investor capital into direct equity stakes in private companies. This structure diverges from a conventional general-partner/limited-partner fund model and is designed to provide individual investors with access to unlisted Mittelstand assets.

The firm targets early-stage startups, expansion-stage firms, and late-stage companies in the DACH region, with a public emphasis on German Mittelstand businesses. Noted investments span industrial technology — such as an organic-semiconductor developer — and enterprise software, as evidenced by the exit of bioprocessing specialist m2p-labs to Beckman Coulter Life Sciences.

FIDURA’s materials and documented deals indicate a direct-investment approach, acquiring equity stakes in operating companies rather than allocating capital to third-party private equity funds. The fund vehicle is structured to hold these direct equity positions on behalf of its investors.

The firm’s public record shows it acting as a lead investor, as demonstrated when it guided m2p-labs to a full acquisition by Beckman Coulter Life Sciences. There is no disclosed co-investment program or track record of partnering with external general partners on club deals.